Maxillary Sinusitis Induced by Medication-Related Osteonecrosis of the Jaw

被引：0
|
作者：
Alamoudi, Abrar A. [1 ,2 ]
Ruprecht, Axel [3 ]
Gohel, Anita [4 ]
Katz, Joseph [4 ]
机构：
[1] Case Western Reserve Univ, Dept Hlth Sci, Sch Med, Cleveland, OH 44106 USA
[2] King Abdulaziz Univ, Dept Oral Diagnost Sci, Jeddah, Saudi Arabia
[3] Univ Iowa, Dept Oral Pathol Radiol & Med, Iowa City, IA USA
[4] Univ Florida Hlth, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 09期
关键词：
bone-related medications; mronj; medication-related osteonecrosis of the jaw; atypical chronic sinusitis; sinusitis; GIANT-CELL TUMOR; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; SURGEONS POSITION PAPER; AMERICAN ASSOCIATION; RISK-FACTORS; BONE;
D O I：
10.7759/cureus.44537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The involvement of maxillary sinuses in patients taking bone -related medications has not been comprehensively considered in the literature, mostly dental. Considering the fact that paranasal sinuses are often captured in dental radiographs, it is incumbent upon dental practitioners to recognize abnormal presentations in the paranasal sinuses to ensure the appropriate management of medication -related osteonecrosis of the jaw (MRONJ). We present a case of a giant cell tumor (GCT) with atypical chronic sinusitis manifestation leading to MRONJ.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw
    Ruggiero, Salvatore L.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 479 - +
  • [22] Interventions for managing medication-related osteonecrosis of the jaw
    Beth-Tasdogan, Natalie H.
    Mayer, Benjamin
    Hussein, Heba
    Zolk, Oliver
    Peter, Jens-Uwe
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (07):
  • [23] Medication-related osteonecrosis of the jaw related to epacadostat and pembrolizumab
    Decaux, J.
    Magremanne, M.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2020, 121 (06) : 740 - 742
  • [24] Medication-related osteonecrosis of the jaw: Prosthodontic considerations
    Ali, Islam E.
    Sumita, Yuka
    JAPANESE DENTAL SCIENCE REVIEW, 2022, 58 : 9 - 12
  • [25] Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw
    Chopra, Kirti
    Malhan, Namrita
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E469 - E477
  • [26] Medication-related osteonecrosis of the jaw associated with aflibercept
    Zarringhalam, P.
    Brizman, E.
    Shakib, K.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (03): : 314 - 315
  • [27] Fibrous Dysplasia and Medication-Related Osteonecrosis of the Jaw
    Metwally, Tarek
    Burke, Andrea
    Tsai, Jeffrey Y.
    Collins, Michael T.
    Boyce, Alison M.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2016, 74 (10) : 1983 - 1999
  • [28] Investigation of the Effectiveness of Surgical Treatment on Maxillary Medication-Related Osteonecrosis of the Jaw: A Literature Review
    Hsu, Kun-Jung
    Hsiao, Szu-Yu
    Chen, Ping-Ho
    Chen, Han-Sheng
    Chen, Chun-Ming
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [29] Pathophysiology of Medication-Related Osteonecrosis of the Jaw-A Minireview
    Tetradis, Sotirios
    Allen, Matthew R.
    Ruggiero, Salvatore L.
    JBMR PLUS, 2023, 7 (08)
  • [30] Position paper on medication-related osteonecrosis of the jaw (MRONJ)
    Svejda B.
    Muschitz C.
    Gruber R.
    Brandtner C.
    Svejda C.
    Gasser R.W.
    Santler G.
    Dimai H.P.
    Wiener Medizinische Wochenschrift, 2016, 166 (1-2) : 68 - 74
12345